© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Zidovudine, often listed under its trade name AZT, has held a vital role in antiretroviral therapy since the 1980s. Originally designed for cancer treatment, researchers found its true calling in the fight against HIV. For many patients, Zidovudine was the key to slowing down the progression of AIDS. Over the years, Zidovudine’s continued use has helped millions by forming the backbone of many HIV treatment regimens, especially in combination therapies. Relying on my professional experience interacting with clinicians and researchers, Zidovudine’s importance extends beyond textbooks. In hospital pharmacies and research labs, this molecule acts as both a symbol of hope and a reminder of the ongoing need for access to essential care and drugs in resource-limited settings.
The material’s physical appearance typically comes as a white to off-white odorless crystalline solid. Sometimes you find it as powder, occasionally as tiny pearls or flakes, depending on the manufacturer’s method. Molecular formula C10H13N5O4 and a formula weight of 267.24 g/mol pinpoint its chemical fingerprint. Zidovudine features a dense hydrogen-bonded structure, unpacked through X-ray crystallography, confirming a stable arrangement. This molecular stability matters for storage and transport, as unexpected breakdown can compromise treatment. Density registers at 1.6 g/cm³, meaning it weighs a little less than most inorganic solids but stores efficiently.
Water solubility rounds out Zidovudine’s appeal in formulation. Most drugs struggle to dissolve thoroughly, leading to issues with dosing and delivery, especially when used in syrup or oral solution for infants and children. Zidovudine dissolves easily in water — up to about 20 mg/mL — making it possible for pharmaceutical companies to prepare both tablet and liquid forms. This isn’t just technical data; for clinicians treating babies born to HIV-positive mothers, dossing must happen quickly after birth, and injectable or dissolvable forms save lives in those crucial moments.
The molecule’s chemical structure brings together a modified nucleoside — it looks enough like regular building blocks of DNA to fool the virus but different enough to stop it from copying itself. Zidovudine’s backbone contains an azido group at the 3’ position of the deoxythymidine ring, disrupting viral replication. Descriptions often show a hexagonal ring, an azido functional group sticking out, and oxygen atoms at four positions. The exact HS Code for global trade usually reads 293499 — for "Other Nucleic Acids and Their Salts, and Their Derivatives," which customs recognizes as a key export and import item within pharmaceutical chemicals. This means drug makers and distributors worldwide can standardize shipments and meet regulatory demands.
Working with Zidovudine, safety always becomes a front-line concern. Zidovudine qualifies as a hazardous material for shipping, despite its therapeutic role, due to risks like skin, eye, and respiratory irritation. Accidental ingestion or significant contact can cause adverse health effects, including nausea, headache, or bone marrow suppression. Lab workers and pharmacists must handle it with care. Industry-standard personal protective equipment — gloves, goggles, lab coats — prevents harmful exposure during weighing, mixing, or packaging. Safe waste handling and spill management standards matter just as much on the manufacturing floor as they do in the hospital pharmacy. As someone who has seen the aftermath from missing small details, following those protocols saves more trouble than it causes.
Drug manufacturers source raw Zidovudine from suppliers specializing in GMP (Good Manufacturing Practices) compliance. Bulk Zidovudine travels in solid powder or crystalline forms, then gets blended with active ingredients and excipients. In active pharmaceutical ingredient (API) production, consistency and purity demand high-precision quality control: expect batch records, analytical data, and certificates with every shipment. Formulators can create oral tablets, syrups, or injectable solutions from the base material. Each application demands attention to density, solubility, and flow characteristics for dosing accuracy. In my career, examining the documentation attached to each raw materials shipment isn’t just a regulatory requirement, it helps uncover inconsistencies that keep a drug like Zidovudine both effective and safe for end-users.
The broader story of Zidovudine covers not only science and manufacturing but also social responsibility and access. While generic production has improved worldwide supply and pricing, far too many still face barriers in getting life-saving antiretrovirals. In my own community work with nonprofit groups, I’ve seen bulk purchases of Zidovudine distributed with international aid shipments, becoming the lifeline for people left out of mainstream healthcare systems. Addressing these gaps remains unfinished business for policymakers, industry leaders, and health organizations. Innovative supply chain management — paired with continued research into improved formulations — can bridge the gaps. Connecting the chemical and physical understanding of Zidovudine with policy and advocacy leads to durable solutions in treating and preventing HIV across the globe.
